{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:10:15Z","timestamp":1793398215672,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T00:00:00Z","timestamp":1693440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T00:00:00Z","timestamp":1693440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Chongqing Natural Science Foundation","award":["No.cstc2020jcyj-jqx0017"],"award-info":[{"award-number":["No.cstc2020jcyj-jqx0017"]}]},{"name":"Chongqing Natural Science Foundation","award":["No.cstc2020jcyj-jqx0017"],"award-info":[{"award-number":["No.cstc2020jcyj-jqx0017"]}]},{"name":"Chongqing Natural Science Foundation","award":["No.cstc2020jcyj-jqx0017"],"award-info":[{"award-number":["No.cstc2020jcyj-jqx0017"]}]},{"DOI":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100014219","name":"National Science Fund for Distinguished Young Scholars","doi-asserted-by":"publisher","award":["No. 81925007"],"award-info":[{"award-number":["No. 81925007"]}],"id":[{"id":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100014219","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Polycystic ovary syndrome (PCOS) is characterized by reproductive dysfunctions and metabolic disorders. This study aims to compare the therapeutic effectiveness of glucagon-like peptide-1 receptor agonist (GLP-1RA) + Metformin (Met) versus cyproterone acetate\/ethinylestradiol (CPA\/EE) + Met in overweight PCOS women and identify potential proteomic biomarkers of disease risk in women with PCOS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this prospective, open-label randomized controlled trial, we recruited 60 overweight PCOS women into two groups at a 1:1 ratio to receive CPA\/EE (2\u2009mg\/day: 2\u2009mg cyproterone acetate and 35-\u03bcg ethinylestradiol,) +Met (1500\u2009mg\/day) or GLP-1 RA (liraglutide, 1.2\u20131.8\u2009mg\/day) +Met (1500\u2009mg\/day) for 12 weeks. The clinical effectiveness and adverse effects were evaluated, followed by plasma proteomic analysis and verification of critical biomarkers by ELISA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Eighty(80%) patients completed the study. Both interventions improved menstrual cycle, polycystic ovaries, LH(luteinizing hormone) and HbA1c(hemoglobin A1c) levels after the 12-week treatment. GLP-1RA + Met was more effective than CPA\/EE + Met in reducing body weight, BMI (Body Mass Index), and waist circumference, FBG(fasting blood glucose), AUCI(area under curve of insulin),TC (Total Cholesterol), IL-6(Interleukin-6) and improving insulin sensitivity, and ovulation in overweight women with PCOS, with acceptable short-term side effects. CPA\/EE + Met was more effective in improving hyperandrogenemia, including T(total testosterone), LH, LH\/FSH(Luteinizing hormone\/follicle-stimulating hormone), SHBG(sex hormone-binding globulin) and FAI (free androgen index). By contract, GLP-1RA+Met group only improved LH. Plasma proteomic analysis revealed that the interventions altered proteins involved in reactive oxygen species detoxification (PRDX6, GSTO1, GSTP1, GSTM2), platelet degranulation (FN1), and the immune response (SERPINB9).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Both CPA\/EE+Met and GLP-1RA + Met treatment improved reproductive functions in overweight PCOS women. GLP-1RA + Met was more effective than CPA\/EE + Met in reducing body weight, BMI, and waist, and improving metabolism, and ovulation in overweight women with PCOS, with acceptable short-term side effects. CPA\/EE + Met was more effective in reducing hyperandrogenemia. The novel plasma biomarkers PRDX6, FN1, and SERPINB9, might be indicators and targets for PCOS treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration ClinicalTials.gov Trial No:<\/jats:title>\n                <jats:p>NCT03151005. Registered 12 May, 2017, <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03151005\">https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03151005<\/jats:ext-link>.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s12020-023-03487-4","type":"journal-article","created":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T19:02:57Z","timestamp":1693508577000},"page":"227-241","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Effects and plasma proteomic analysis of GLP-1RA versus CPA\/EE, in combination with metformin, on overweight PCOS women: a randomized controlled trial"],"prefix":"10.1007","volume":"83","author":[{"given":"Mingyu","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rufei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiliang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqing","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiujie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongting","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1071-8131","authenticated-orcid":false,"given":"Min","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,31]]},"reference":[{"key":"3487_CR1","first-page":"104","volume":"6","author":"EK Barthelmess","year":"2014","unstructured":"E.K. Barthelmess, R.K. Naz, Polycystic ovary syndrome: current status and future perspective. Front. Biosci. (Elite Ed.) 6, 104\u201319 (2014)","journal-title":"Front. Biosci. (Elite Ed.)"},{"issue":"5","key":"3487_CR2","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1210\/er.2015-1018","volume":"36","author":"DA Dumesic","year":"2015","unstructured":"D.A. Dumesic, S.E. Oberfield, E. Stener-Victorin, J.C. Marshall, J.S. Laven, R.S. Legro, Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome. Endocr. Rev. 36(5), 487\u2013525 (2015)","journal-title":"Endocr. Rev."},{"key":"3487_CR3","doi-asserted-by":"crossref","unstructured":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human reproduction (Oxford, England);19(1):41\u22127 (2004)","DOI":"10.1093\/humrep\/deh098"},{"issue":"10","key":"3487_CR4","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1093\/humrep\/des232","volume":"27","author":"BO Yildiz","year":"2012","unstructured":"B.O. Yildiz, G. Bozdag, Z. Yapici, I. Esinler, H. Yarali, Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum. Reprod. (Oxf., Engl.) 27(10), 3067\u201373 (2012)","journal-title":"Hum. Reprod. (Oxf., Engl.)"},{"issue":"6","key":"3487_CR5","doi-asserted-by":"publisher","first-page":"505","DOI":"10.2217\/WHE.13.53","volume":"9","author":"BO Yildiz","year":"2013","unstructured":"B.O. Yildiz, Polycystic ovary syndrome: is obesity a symptom? Women\u2019s health (Lond., Engl.) 9(6), 505\u20137 (2013)","journal-title":"Women\u2019s health (Lond., Engl.)"},{"issue":"5","key":"3487_CR6","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/j.fertnstert.2010.03.081","volume":"94","author":"K Farrell","year":"2010","unstructured":"K. Farrell, M.H. Antoni, Insulin resistance, obesity, inflammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions. Fertil. Steril. 94(5), 1565\u201374 (2010)","journal-title":"Fertil. Steril."},{"issue":"5","key":"3487_CR7","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrendo.2018.24","volume":"14","author":"HF Escobar-Morreale","year":"2018","unstructured":"H.F. Escobar-Morreale, Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat. Rev. Endocrinol. 14(5), 270\u201384 (2018)","journal-title":"Nat. Rev. Endocrinol."},{"issue":"4","key":"3487_CR8","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1210\/jc.2012-2937","volume":"98","author":"U Ezeh","year":"2013","unstructured":"U. Ezeh, M. Pall, R. Mathur, D. Dey, D. Berman, I.Y. Chen, D.A. Dumesic, R. Azziz, Effects of endogenous androgens and abdominal fat distribution on the interrelationship between insulin and non-insulin-mediated glucose uptake in females. J. Clin. Endocrinol. Metab. 98(4), 1541\u20138 (2013)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"3487_CR9","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1080\/13625187.2017.1317735","volume":"22","author":"X Ruan","year":"2017","unstructured":"X. Ruan, A. Kubba, A. Aguilar, A.O. Mueck, Use of cyproterone acetate\/ethinylestradiol in polycystic ovary syndrome: rationale and practical aspects. Eur. J. Contracept. Reprod. Health Care 22(3), 183\u201390 (2017)","journal-title":"Eur. J. Contracept. Reprod. Health Care"},{"key":"3487_CR10","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.2147\/DDDT.S141675","volume":"11","author":"YW Wang","year":"2017","unstructured":"Y.W. Wang, S.J. He, X. Feng, J. Cheng, Y.T. Luo, L. Tian, Q. Huang, Metformin: a review of its potential indications. Drug Des. Dev. Ther. 11, 2421\u20139 (2017)","journal-title":"Drug Des. Dev. Ther."},{"issue":"8","key":"3487_CR11","doi-asserted-by":"publisher","first-page":"e2695","DOI":"10.1210\/clinem\/dgaa285","volume":"105","author":"H Cena","year":"2020","unstructured":"H. Cena, L. Chiovato, R.E. Nappi, Obesity, polycystic ovary syndrome, and infertility: A new avenue for GLP-1 receptor agonists. J. Clin. Endocrinol. Metab. 105(8), e2695\u2013709 (2020)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3487_CR12","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.3389\/fphar.2018.01168","volume":"9","author":"Y Jiang","year":"2018","unstructured":"Y. Jiang, Z. Wang, B. Ma, L. Fan, N. Yi, B. Lu, Q. Wang, R. Liu, GLP-1 improves adipocyte insulin sensitivity following induction of endoplasmic reticulum stress. Front. Pharmacol. 9, 1168 (2018)","journal-title":"Front. Pharmacol."},{"issue":"1","key":"3487_CR13","first-page":"83","volume":"15","author":"BF Zhou","year":"2002","unstructured":"B.F. Zhou, Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults\u2013study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed. Environ. Sci. 15(1), 83\u201396 (2002)","journal-title":"Biomed. Environ. Sci."},{"issue":"17","key":"3487_CR14","first-page":"2524","volume":"30","author":"M Choi","year":"2014","unstructured":"M. Choi, C.Y. Chang, T. Clough, D. Broudy, T. Killeen, B. MacLean, O. Vitek, MSstats: an R package for statistical analysis of quantitative mass spectrometry-based proteomic experiments. Bioinforma. (Oxf., Engl.) 30(17), 2524\u20136 (2014)","journal-title":"Bioinforma. (Oxf., Engl.)"},{"issue":"7","key":"3487_CR15","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"M.E. Ritchie, B. Phipson, D. Wu, Y. Hu, C.W. Law, W. Shi, G.K. Smyth, limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic acids Res. 43(7), e47 (2015)","journal-title":"Nucleic acids Res."},{"issue":"1","key":"3487_CR16","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W Huang da","year":"2009","unstructured":"W. Huang da, B.T. Sherman, R.A. Lempicki, Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4(1), 44\u201357 (2009)","journal-title":"Nat. Protoc."},{"issue":"11","key":"3487_CR17","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"P. Shannon, A. Markiel, O. Ozier, N.S. Baliga, J.T. Wang, D. Ramage, N. Amin, B. Schwikowski, T. Ideker, Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13(11), 2498\u2013504 (2003)","journal-title":"Genome Res."},{"issue":"36","key":"3487_CR18","doi-asserted-by":"publisher","first-page":"5526","DOI":"10.2174\/1381612822666160720155855","volume":"22","author":"P Moghetti","year":"2016","unstructured":"P. Moghetti, Insulin resistance and polycystic ovary syndrome. Curr. Pharm. Des. 22(36), 5526\u201334 (2016)","journal-title":"Curr. Pharm. Des."},{"issue":"12","key":"3487_CR19","doi-asserted-by":"publisher","first-page":"3320","DOI":"10.2337\/diacare.26.12.3320","volume":"26","author":"JF Ascaso","year":"2003","unstructured":"J.F. Ascaso, S. Pardo, J.T. Real, R.I. Lorente, A. Priego, R. Carmena, Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care 26(12), 3320\u20135 (2003)","journal-title":"Diabetes Care"},{"issue":"1","key":"3487_CR20","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1210\/jc.2005-1696","volume":"91","author":"F Gonz\u00e1lez","year":"2006","unstructured":"F. Gonz\u00e1lez, N.S. Rote, J. Minium, J.P. Kirwan, Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 91(1), 336\u201340 (2006)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"3487_CR21","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1161\/01.ATV.0000165699.41301.c5","volume":"25","author":"S Fateh-Moghadam","year":"2005","unstructured":"S. Fateh-Moghadam, Z. Li, S. Ersel, T. Reuter, P. Htun, U. Pl\u00f6ckinger, W. Bocksch, R. Dietz, M. Gawaz, Platelet degranulation is associated with progression of intima-media thickness of the common carotid artery in patients with diabetes mellitus type 2. Arteriosclerosis Thrombosis Vasc Biol. 25(6), 1299\u2013303 (2005)","journal-title":"Arteriosclerosis Thrombosis Vasc Biol."},{"issue":"3","key":"3487_CR22","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1093\/humrep\/dem380","volume":"23","author":"M Cort\u00f3n","year":"2008","unstructured":"M. Cort\u00f3n, J.I. Botella-Carretero, J.A. L\u00f3pez, E. Camafeita, J.L. San Mill\u00e1n, H.F. Escobar-Morreale, B. Peral, Proteomic analysis of human omental adipose tissue in the polycystic ovary syndrome using two-dimensional difference gel electrophoresis and mass spectrometry. Hum. Reprod. (Oxf., Engl.) 23(3), 651\u201361 (2008)","journal-title":"Hum. Reprod. (Oxf., Engl.)"},{"issue":"6-7","key":"3487_CR23","doi-asserted-by":"publisher","first-page":"A471","DOI":"10.1016\/j.autrev.2011.11.010","volume":"11","author":"J Petr\u00edkov\u00e1","year":"2012","unstructured":"J. Petr\u00edkov\u00e1, I. Laz\u00farov\u00e1, Ovarian failure and polycystic ovary syndrome. Autoimmun. Rev. 11(6-7), A471\u20138 (2012)","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"3487_CR24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1056\/NEJMct0707092","volume":"358","author":"JE Nestler","year":"2008","unstructured":"J.E. Nestler, Metformin for the treatment of the polycystic ovary syndrome. N. Engl. J. Med. 358(1), 47\u201354 (2008)","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"3487_CR25","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1097\/CM9.0000000000001712","volume":"134","author":"RL Ma","year":"2021","unstructured":"R.L. Ma, Y. Deng, Y.F. Wang, S.Y. Zhu, X.S. Ding, A.J. Sun, Short-term combined treatment with exenatide and metformin for overweight\/obese women with polycystic ovary syndrome. Chin. Med. J. (Engl.) 134(23), 2882\u20139 (2021)","journal-title":"Chin. Med. J. (Engl.)"},{"issue":"1","key":"3487_CR26","first-page":"24","volume":"65","author":"VB Chueire","year":"2021","unstructured":"V.B. Chueire, E. Muscelli, Effect of free fatty acids on insulin secretion, insulin sensitivity and incretin effect - a narrative review. Arch. Endocrinol. Metab. 65(1), 24\u201331 (2021)","journal-title":"Arch. Endocrinol. Metab."},{"key":"3487_CR27","doi-asserted-by":"publisher","first-page":"945609","DOI":"10.3389\/fendo.2022.945609","volume":"13","author":"C Xing","year":"2022","unstructured":"C. Xing, H. Zhao, J. Zhang, B. He, Effect of metformin versus metformin plus liraglutide on gonadal and metabolic profiles in overweight patients with polycystic ovary syndrome. Front Endocrinol. (Lausanne) 13, 945609 (2022)","journal-title":"Front Endocrinol. (Lausanne)"},{"issue":"3","key":"3487_CR28","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/13625180400007751","volume":"9","author":"P Villaseca","year":"2004","unstructured":"P. Villaseca, P. Hormaza, I. Cardenas, E. Oestreicher, E. Arteaga, Ethinylestradiol\/cyproterone acetate in polycystic ovary syndrome: lipid and carbohydrate changes. Eur. J. Contracept. Reprod. Health Care 9(3), 155\u201365 (2004)","journal-title":"Eur. J. Contracept. Reprod. Health Care"},{"issue":"5","key":"3487_CR29","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1210\/er.2015-1104","volume":"37","author":"RL Rosenfield","year":"2016","unstructured":"R.L. Rosenfield, D.A. Ehrmann, The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr. Rev. 37(5), 467\u2013520 (2016)","journal-title":"Endocr. Rev."},{"issue":"6","key":"3487_CR30","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1007\/s00404-018-4762-0","volume":"297","author":"X Ruan","year":"2018","unstructured":"X. Ruan, J. Song, M. Gu, L. Wang, H. Wang, A.O. Mueck, Effect of Diane-35, alone or in combination with orlistat or metformin in Chinese polycystic ovary syndrome patients. Arch. Gynecol. Obstet. 297(6), 1557\u201363 (2018)","journal-title":"Arch. Gynecol. Obstet."},{"issue":"4","key":"3487_CR31","doi-asserted-by":"publisher","first-page":"R157","DOI":"10.1530\/EJE-16-0374","volume":"175","author":"R Pasquali","year":"2016","unstructured":"R. Pasquali, E. Diamanti-Kandarakis, A. Gambineri, MANAGEMENT OF ENDOCRINE DISEASE: Secondary polycystic ovary syndrome: theoretical and practical aspects. Eur. J. Endocrinol. 175(4), R157\u201369 (2016)","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"3487_CR32","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1067\/mpd.2001.109603","volume":"138","author":"VD Lewy","year":"2001","unstructured":"V.D. Lewy, K. Danadian, S.F. Witchel, S. Arslanian, Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome. J. Pediatr. 138(1), 38\u201344 (2001)","journal-title":"J. Pediatr."},{"issue":"8","key":"3487_CR33","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.1210\/jc.2010-0220","volume":"95","author":"M Insenser","year":"2010","unstructured":"M. Insenser, M.A. Mart\u00ednez-Garc\u00eda, R. Montes, J.L. San-Mill\u00e1n, H.F. Escobar-Morreale, Proteomic analysis of plasma in the polycystic ovary syndrome identifies novel markers involved in iron metabolism, acute-phase response, and inflammation. J. Clin. Endocrinol. Metab. 95(8), 3863\u201370 (2010)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"3487_CR34","first-page":"1409","volume":"45","author":"L Li","year":"2020","unstructured":"L. Li, J. Zhang, J. Zeng, B. Liao, X. Peng, T. Li, J. Li, Q. Tan, X. Li, Y. Yang, Z. Chen, Z. Liang, Proteomics analysis of potential serum biomarkers for insulin resistance in patients with polycystic ovary syndrome. Int. J. Mol. Med. 45(5), 1409\u201316 (2020)","journal-title":"Int. J. Mol. Med."},{"key":"3487_CR35","doi-asserted-by":"publisher","first-page":"8589318","DOI":"10.1155\/2016\/8589318","volume":"2016","author":"T Zuo","year":"2016","unstructured":"T. Zuo, M. Zhu, W. Xu, Roles of oxidative stress in polycystic ovary syndrome and cancers. Oxid. Med. Cell. Longev. 2016, 8589318 (2016)","journal-title":"Oxid. Med. Cell. Longev."},{"key":"3487_CR36","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.canlet.2018.06.028","volume":"433","author":"A Chatterjee","year":"2018","unstructured":"A. Chatterjee, S. Gupta, The multifaceted role of glutathione S-transferases in cancer. Cancer Lett. 433, 33\u201342 (2018)","journal-title":"Cancer Lett."},{"issue":"1","key":"3487_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-84586-y","volume":"11","author":"ASM Moin","year":"2021","unstructured":"A.S.M. Moin, T. Sathyapalan, I. Diboun, M.A. Elrayess, A.E. Butler, S.L. Atkin, Metabolic consequences of obesity on the hypercoagulable state of polycystic ovary syndrome. Sci. Rep. 11(1), 5320 (2021)","journal-title":"Sci. Rep."},{"issue":"11","key":"3487_CR38","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1093\/humrep\/det341","volume":"28","author":"X Zhang","year":"2013","unstructured":"X. Zhang, C. Zhang, S. Shen, Y. Xia, L. Yi, Q. Gao, Y. Wang, Dehydroepiandrosterone induces ovarian and uterine hyperfibrosis in female rats. Hum. Reprod. (Oxf., Engl.) 28(11), 3074\u201385 (2013)","journal-title":"Hum. Reprod. (Oxf., Engl.)"},{"issue":"6","key":"3487_CR39","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.2337\/db15-1141","volume":"65","author":"A Cameron-Vendrig","year":"2016","unstructured":"A. Cameron-Vendrig, A. Reheman, M.A. Siraj, X.R. Xu, Y. Wang, X. Lei, T. Afroze, E. Shikatani, O. El-Mounayri, H. Noyan, R. Weissleder, H. Ni, M. Husain, Glucagon-like peptide 1 receptor activation attenuates platelet aggregation and thrombosis. Diabetes 65(6), 1714\u201323 (2016)","journal-title":"Diabetes"},{"issue":"6","key":"3487_CR40","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s00395-011-0216-6","volume":"106","author":"Y Ye","year":"2011","unstructured":"Y. Ye, J.R. Perez-Polo, D. Aguilar, Y. Birnbaum, The potential effects of anti-diabetic medications on myocardial ischemia-reperfusion injury. Basic Res. Cardiol. 106(6), 925\u201352 (2011)","journal-title":"Basic Res. Cardiol."},{"issue":"4","key":"3487_CR41","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/cdd.2009.169","volume":"17","author":"D Kaiserman","year":"2010","unstructured":"D. Kaiserman, P.I. Bird, Control of granzymes by serpins. Cell Death Differ. 17(4), 586\u201395 (2010)","journal-title":"Cell Death Differ."},{"issue":"44","key":"3487_CR42","doi-asserted-by":"publisher","first-page":"27802","DOI":"10.1074\/jbc.271.44.27802","volume":"271","author":"J Sun","year":"1996","unstructured":"J. Sun, C.H. Bird, V. Sutton, L. McDonald, P.B. Coughlin, T.A. De Jong, J.A. Trapani, P.I. Bird, A cytosolic granzyme B inhibitor related to the viral apoptotic regulator cytokine response modifier A is present in cytotoxic lymphocytes. J. Biol. Chem. 271(44), 27802\u20139 (1996)","journal-title":"J. Biol. Chem."},{"key":"3487_CR43","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ejogrb.2016.01.009","volume":"198","author":"E Oztas","year":"2016","unstructured":"E. Oztas, S. Ozler, A. Tokmak, N. Yilmaz, H.T. Celik, F.H. Kazanc\u0131, N. Danisman, M. Ergin, H.I. Yakut, Increased levels of serum granzyme-B is associated with insulin resistance and increased cardiovascular risk in adolescent polycystic ovary syndrome patients. Eur. J. Obstet. Gynecol. Reprod. Biol. 198, 89\u201393 (2016)","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"5","key":"3487_CR44","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.immuni.2008.08.014","volume":"29","author":"SS Metkar","year":"2008","unstructured":"S.S. Metkar, C. Menaa, J. Pardo, B. Wang, R. Wallich, M. Freudenberg, S. Kim, S.M. Raja, L. Shi, M.M. Simon, C.J. Froelich, Human and mouse granzyme A induce a proinflammatory cytokine response. Immunity 29(5), 720\u201333 (2008)","journal-title":"Immunity"},{"issue":"1","key":"3487_CR45","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.brainres.2005.03.011","volume":"1044","author":"CR Abbott","year":"2005","unstructured":"C.R. Abbott, M. Monteiro, C.J. Small, A. Sajedi, K.L. Smith, J.R. Parkinson, M.A. Ghatei, S.R. Bloom, The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res. 1044(1), 127\u201331 (2005)","journal-title":"Brain Res."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03487-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-023-03487-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03487-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T09:33:33Z","timestamp":1706002413000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-023-03487-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,31]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["3487"],"URL":"https:\/\/doi.org\/10.1007\/s12020-023-03487-4","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,31]]},"assertion":[{"value":"10 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The trial was approved by the Ethics Committee of the Second Hospital Affiliated to the Army Medical University. The study methodology was registered on clinical trials.gov: NCT03151005.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The study was approved by the institution board of study and informed consent was obtained from each participant included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}